ReShape Lifesciences (RSLS) Competitors $5.34 +0.30 (+5.95%) (As of 11:35 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends RSLS vs. IRIX, HOOK, RMTI, EDAP, ABT, ISRG, SYK, BSX, MDT, and BDXShould you be buying ReShape Lifesciences stock or one of its competitors? The main competitors of ReShape Lifesciences include IRIDEX (IRIX), Hookipa Pharma (HOOK), Rockwell Medical (RMTI), Edap Tms (EDAP), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), and Becton, Dickinson and Company (BDX). ReShape Lifesciences vs. IRIDEX Hookipa Pharma Rockwell Medical Edap Tms Abbott Laboratories Intuitive Surgical Stryker Boston Scientific Medtronic Becton, Dickinson and Company ReShape Lifesciences (NASDAQ:RSLS) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations. Which has better earnings and valuation, RSLS or IRIX? IRIDEX has higher revenue and earnings than ReShape Lifesciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReShape Lifesciences$8.68M0.44-$11.39MN/AN/AIRIDEX$51.87M0.55-$9.57M-$0.67-2.58 Does the MarketBeat Community prefer RSLS or IRIX? ReShape Lifesciences received 126 more outperform votes than IRIDEX when rated by MarketBeat users. Likewise, 66.11% of users gave ReShape Lifesciences an outperform vote while only 65.54% of users gave IRIDEX an outperform vote. CompanyUnderperformOutperformReShape LifesciencesOutperform Votes39866.11% Underperform Votes20433.89% IRIDEXOutperform Votes27265.54% Underperform Votes14334.46% Do analysts prefer RSLS or IRIX? IRIDEX has a consensus target price of $2.00, suggesting a potential upside of 15.61%. Given IRIDEX's higher probable upside, analysts plainly believe IRIDEX is more favorable than ReShape Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReShape Lifesciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00IRIDEX 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, RSLS or IRIX? ReShape Lifesciences has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Do institutionals and insiders believe in RSLS or IRIX? 22.1% of ReShape Lifesciences shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 0.1% of ReShape Lifesciences shares are owned by insiders. Comparatively, 7.3% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is RSLS or IRIX more profitable? IRIDEX has a net margin of -22.79% compared to ReShape Lifesciences' net margin of -86.36%. ReShape Lifesciences' return on equity of -179.83% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets ReShape Lifesciences-86.36% -179.83% -91.48% IRIDEX -22.79%-192.95%-33.97% Does the media favor RSLS or IRIX? In the previous week, ReShape Lifesciences had 1 more articles in the media than IRIDEX. MarketBeat recorded 5 mentions for ReShape Lifesciences and 4 mentions for IRIDEX. ReShape Lifesciences' average media sentiment score of 0.52 beat IRIDEX's score of 0.11 indicating that ReShape Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ReShape Lifesciences 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryReShape Lifesciences and IRIDEX tied by winning 7 of the 14 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RSLS vs. The Competition Export to ExcelMetricReShape LifesciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.79M$4.43B$5.08B$8.80BDividend YieldN/A36.79%5.02%4.07%P/E RatioN/A13.5791.2813.60Price / Sales0.4444.221,226.2187.40Price / CashN/A52.2739.4536.27Price / Book2.565.776.906.33Net Income-$11.39M$13.76M$118.83M$225.93M7 Day Performance3.29%-0.99%-1.92%-0.96%1 Month Performance-19.34%0.71%-3.75%1.06%1 Year Performance-55.54%51.46%31.37%26.59% ReShape Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RSLSReShape Lifesciences0.1281 of 5 stars$5.34+6.0%N/A-62.2%$3.79M$8.68M0.0050Gap UpIRIXIRIDEX0.6933 of 5 stars$1.73-0.6%$2.00+15.6%-17.1%$28.79M$51.87M0.00120HOOKHookipa Pharma2.4671 of 5 stars$2.52-7.4%$38.33+1,421.2%-46.4%$30.39M$20.13M-0.6856Analyst ForecastGap DownRMTIRockwell Medical4.1708 of 5 stars$2.23-4.3%$7.00+213.9%+19.5%$72.07M$83.61M-46.60300Analyst DowngradeEDAPEdap Tms2.4635 of 5 stars$2.62+6.9%$19.00+625.2%-45.7%$97.20M$65.42M-4.03307Analyst DowngradeABTAbbott Laboratories4.9711 of 5 stars$116.06+0.1%$130.07+12.1%+14.6%$201.30B$40.11B35.24114,000Positive NewsISRGIntuitive Surgical4.6567 of 5 stars$547.63+1.1%$524.61-4.2%+74.0%$195.05B$7.12B87.1113,676Analyst UpgradePositive NewsSYKStryker4.9421 of 5 stars$388.39+0.7%$393.65+1.4%+33.3%$148.06B$20.50B41.5952,000Analyst RevisionPositive NewsBSXBoston Scientific4.6004 of 5 stars$91.52+1.5%$93.39+2.0%+65.6%$134.88B$14.24B74.5248,000Analyst ForecastMDTMedtronic4.9595 of 5 stars$84.86+0.9%$95.19+12.2%+11.9%$108.83B$32.36B25.8695,000Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageBDXBecton, Dickinson and Company4.9899 of 5 stars$225.03+1.2%$283.00+25.8%-4.8%$65.04B$20.18B37.4473,000Positive News Related Companies and Tools Related Companies IRIX Alternatives HOOK Alternatives RMTI Alternatives EDAP Alternatives ABT Alternatives ISRG Alternatives SYK Alternatives BSX Alternatives MDT Alternatives BDX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RSLS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
